Hansoh Pharmaceutical Group Company Limited (HKG:3692)
Hong Kong · Delayed Price · Currency is HKD 36.02
+0.30 (0.84%)
Aug 29, 2025, 4:08 PM HKT
HKG:3692 Market Cap
HKG:3692 has a market cap or net worth of 218.06 billion as of August 29, 2025. Its market cap has increased by 99.87% in one year.
Market Cap
218.06B
Enterprise Value
188.47B
Revenue
14.45B
Ranking
n/a
PE Ratio
40.94
Stock Price
36.02
Market Cap Chart
Since June 14, 2019, HKG:3692's market cap has increased from 111.27B to 218.06B, an increase of 95.98%. That is a compound annual growth rate of 11.44%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 28, 2025 | 216.24B | 110.88% |
| Dec 31, 2024 | 102.55B | 9.84% |
| Dec 29, 2023 | 93.36B | 6.25% |
| Dec 30, 2022 | 87.86B | -21.92% |
| Dec 31, 2021 | 112.52B | -49.44% |
| Dec 31, 2020 | 222.55B | 48.44% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jun 14, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines | 255.56B |
| JD Health International | 199.69B |
| Innovent Biologics | 155.26B |
| Sino Biopharmaceutical | 138.43B |
| Akeso | 136.61B |
| WuXi Biologics | 126.35B |
| CSPC Pharmaceutical Group | 107.93B |
| Sichuan Kelun-Biotech Biopharmaceutical | 103.76B |